Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.
Soleno Therapeutics stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy …
معلومات السوق الآنية عبر فئات الأصول
| المطلع | المنصب | Date | النوع | القيمة |
|---|---|---|---|---|
| Marshall Fiona | Officer | Feb 12 '26 | Proposed Sale | 4960277,0 |
| Bulto Carulla Victor | Officer | Feb 09 '26 | Proposed Sale | 1171576,0 |
| Marshall Fiona | Officer | May 23 '25 | Proposed Sale | 1690181,0 |
| Kowalski Robert William | Officer | Apr 30 '25 | Proposed Sale | 137297,0 |
المصدر: FinViz — قد تكون البيانات متأخرة
أخبار منتقاة بالذكاء الاصطناعي تؤثر على سعر NVS والمشاعر والاتجاه
Soleno Therapeutics stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy …
The Swiss National Bank’s determination to cap gains in the franc will draw the spotlight in a decision that is …
تحليل متعدد المزودين بالذكاء الاصطناعي